|

Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

RECRUITINGPhase 4Sponsored by Kasr El Aini Hospital
Actively Recruiting
PhasePhase 4
SponsorKasr El Aini Hospital
Started2026-02-01
Est. completion2026-12
Eligibility
Age2 Years – 6 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07427446

Summary

Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups. Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)

Eligibility

Age: 2 Years – 6 YearsHealthy volunteers accepted
Inclusion Criteria:

* Scheduled for elective cardiac catheterization under general anesthesia.

Exclusion Criteria:

* neurological disorder, psychiatric disease, or current psychoactive medication.
* allergy.
* significant systemic comorbidities.

Conditions2

Emergence DeliriumHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.